Tower Research Capital (TRC)’s Rosetta Genomics Ltd. ROSG Stock Holding History

Tower Research Capital (TRC)’s Portfolio ROSG Stock Details ROSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-965	Closed	-$39K	–	5326
2015 Q2	$39K	Buy	965 +18	+2%	+$770	﹤0.01%	1569
2015 Q1	$35K	Buy	947 +758	+401%	+$28.7K	﹤0.01%	1780
2014 Q4	$5K	Buy	189 +161	+575%	+$5.23K	﹤0.01%	2794
2014 Q3	$1K	Sell	28 -55	-66%	-$2.5K	﹤0.01%	4258
2014 Q2	$4K	Sell	83 -199	-71%	-$9.86K	﹤0.01%	3095
2014 Q1	$17K	Sell	282 -3,128	-92%	-$162K	﹤0.01%	2084
2013 Q4	$119K	Buy	3,410 +2,875	+537%	+$99.8K	0.02%	770
2013 Q3	$20K	Buy	535 +166	+45%	+$6.74K	﹤0.01%	2703
2013 Q2	$15K	Buy	+369	New	+$16.4K	﹤0.01%	2006

Other funds holding ROSG

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ICAS

Investors Capital Advisory Services Lynnfield, Massachusetts $521M AUM 1.51% 1-Year Est. Return

RCM

Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return

Gerstein Fisher New York $811M AUM 13.96% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tower Research Capital (TRC)'s ROSG Position: Q3 2015 in Review

Tower Research Capital (TRC) sold out of Rosetta Genomics Ltd. (ROSG) in Q3 2015, closing a stake of 965 shares — an estimated $39K sold.

Tower Research Capital (TRC) first reported a position in ROSG in Q2 2013 and held it in 9 quarters. The position peaked at $119K in Q4 2013. 11 funds tracked by Wall St. Rank hold ROSG as of Q3 2015.

Tower Research Capital (TRC) reported no remaining Rosetta Genomics Ltd. position as of Q3 2015 after selling out during the quarter.
Tower Research Capital (TRC) sold 965 Rosetta Genomics Ltd. shares in Q3 2015, an estimated $39K.
Tower Research Capital (TRC) first reported a position in Rosetta Genomics Ltd. in Q2 2013 and held it in 9 quarters.
Tower Research Capital (TRC)'s Rosetta Genomics Ltd. position peaked at $119K in Q4 2013.
11 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q3 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2015, filed 13 Nov 2015.